— Know what they know.
Not Investment Advice

ELTP OTC

Elite Pharmaceuticals, Inc.
1W: -11.4% 1M: -17.2% 3M: -37.6% YTD: -54.3% 1Y: -65.6% 3Y: +154.1% 5Y: +357.3%
$0.23
+0.00 (+0.73%)
 
Weekly Expected Move ±6.3%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $246.3M mcap · 836M float · 0.086% daily turnover · Short 27% of daily vol

📊 Key Metrics

TTM
$149M
Revenue
+77.1% YoY
$45M
Net Income
+1140.0% YoY
$23M
Free Cash Flow
+362.9% YoY
50.1%
Gross Margin
27.1%
Op. Margin
45.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE58.9%
ROA38.2%
ROIC-0.1%

Valuation

P/E4.6
P/B2.4
EV/EBITDA-787.9

Leverage

Debt/Equity0.06
Current Ratio6.45
Interest Cov.89.3x

Quality Scores

Piotroski F6/9
Altman Z7.92
Beneish M-150.44

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms